Express Scripts, the nation’s largest pharmacy benefits manager, will limit the number and strength of opioid drugs prescribed to first-time users starting in September 2017 as part of a wide ...

Express Scripts said it will pay $9.3 million of the settlement total to the states and the District of Columbia. Another $200,000 will provide no more than $25 apiece to individual patients to ...

CVS Health, Express Scripts’ rival and the No. 2 pharmacy benefit manager in the country, has sided with California-based Gilead Sciences and its two hepatitis C drugs, Sovaldi and Harvoni.